– Reuters Citing Sources
Related Posts
Entrada Therapeutics Stock Gains On Licensing Pact With Vertex For Form Of Neuromuscular Disorder
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and Entrada Therapeutics Inc (NASDAQ:TRDA) announced a global collaboration focused on discovering and developing intracellular Endosomal Escape Vehicle (EEV)…
Atlantic Equities Maintains Neutral on Johnson & Johnson, Raises Price Target to $168
Atlantic Equities analyst Steve Chesney maintains Johnson & Johnson (NYSE:JNJ) with a Neutral and raises the price target from $160 to $168.
NBA Board Of Governors Initiates Process For Mark Cuban To Sell Majority Stake In Dallas Mavericks
Potential buyers include billionaire casino owners Miriam Adelson and the Las Vegas Sands Casino family.